Brief: Glenmark Pharma Launches Winlevi 10 Mg/G Cream In Key European Markets
11/06/2026 05:52
BRIEF-Glenmark Pharma Launches Winlevi 10 Mg/G Cream In Key European Markets June 11 (Reuters) - Glenmark Pharmaceuticals Ltd GLEN.NS:
GLENMARK PHARMA - LAUNCHES WINLEVI (CLASCOTERONE) 10 MG/G CREAM IN KEY EUROPEAN MARKETS
Source text: ID:nBSE1cHzrV
Further company coverage: GLEN.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Glenmark Pharmaceuticals
See all newsBrief: Glenmark Pharma Says Unit Launches Ryaltris Nasal Spray In Brazil For Allergic Rhinitis
Brief: Glenmark Pharma US Unit Launches Calcium Gluconate Injection USP In Multiple Vial Sizes
India's Glenmark Pharma gains most in three weeks on US approval for Flonase nasal spray
Brief: Glenmark Pharma Gets U.S. FDA Approval For Fluticasone Propionate Nasal Spray 0.05 Mg/Spray
India's Glenmark Pharmaceuticals falls as brokerage flags softer-than-expected quarter